Cargando…
Proteomic characterization of microdissected breast tissue environment provides a protein‐level overview of malignant transformation
Both healthy and cancerous breast tissue is heterogeneous, which is a bottleneck for proteomics‐based biomarker analysis, as it obscures the cellular origin of a measured protein. We therefore aimed at obtaining a protein‐level interpretation of malignant transformation through global proteome analy...
Autores principales: | Braakman, René B. H., Stingl, Christoph, Tilanus‐Linthorst, Madeleine M. A., van Deurzen, Carolien H. M., Timmermans, Mieke A. M., Smid, Marcel, Foekens, John A., Luider, Theo M., Martens, John W. M., Umar, Arzu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347865/ https://www.ncbi.nlm.nih.gov/pubmed/28058811 http://dx.doi.org/10.1002/pmic.201600213 |
Ejemplares similares
-
Proteomics Pipeline for Biomarker Discovery of Laser Capture Microdissected Breast Cancer Tissue
por: Liu, Ning Qing, et al.
Publicado: (2012) -
Global proteomic characterization of microdissected estrogen receptor positive breast tumors
por: De Marchi, Tommaso, et al.
Publicado: (2015) -
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015) -
4‐protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015) -
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2017)